Skip to main content

GSAC Engineering Secures Multi-Year Recurring Revenue Contract

GelStat’s Subsidiary Awarded Renewal for Security Monitoring Services and Expands Deployment of Proprietary iCAS Technology Across Three Secure Government-Operated Facilities in Florida MIAMI, June 10, 2025 (GLOBE NEWSWIRE) — GelStat Corporation (“GelStat” or the “Company”) (OTC: GSAC), a development stage company currently focused on the research, development, and marketing of engineered solutions for the industrial security industries, today announced the renewal of a service contract for its subsidiary, GSAC Engineering (“GSACe”), totaling approximately $550,000 over a four-year term. With expected additional work-orders the revenue could exceed $1 million over that period. Effective March 19, 2025, the agreement provides for structured recurring payments through January 31, 2029. The renewal includes...

Continue reading

Enlivex Therapeutics to Present Clinical Data of Allocetra in Osteoarthritis at EULAR 25 European Congress of Rheumatology

Ness-Ziona, Israel, June 10, 2025 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that it will present a poster at the European Alliance of Associations for Rheumatology (EULAR) European Congress of Rheumatology, taking place June 11-14, 2025, in Barcelona, Spain. The Company’s presentation will feature data from the ongoing clinical study evaluating Allocetra™, Enlivex’s proprietary, off-the-shelf macrophage reprogramming cell therapy, in patients with knee osteoarthritis. Allocetra™ is designed to reprogram macrophages into a homeostatic state, thereby promoting immune balance and resolution of chronic inflammation. Allocetra™ has demonstrated favorable safety and promising efficacy signals in Phase...

Continue reading

NeoVolta Distributor Orders Top $3M in Single Quarter

Channel Momentum Highlights Growing Market Acceptance for NeoVolta Energy Storage Solutions SAN DIEGO, June 10, 2025 (GLOBE NEWSWIRE) — NeoVolta Inc. (NASDAQ: NEOV), a U.S.-based energy technology company delivering scalable energy storage solutions for resilient residential and commercial power infrastructure, today announced that distributor purchase orders have exceeded $3 million in the current quarter—the highest quarterly total from the channel in company history. “These distributor orders represent a major milestone in our expansion strategy,” said Ardes Johnson, CEO of NeoVolta. “They show that demand for NeoVolta systems is scaling across the country through established installer networks—not just direct sales.” The surge in purchase orders came from three major solar and energy equipment distributors in the U.S. Their...

Continue reading

Iovance Biotherapeutics to Present at Upcoming Conference

SAN CARLOS, Calif., June 10, 2025 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced that senior leadership plans to present at the following conference:Goldman Sachs Global Healthcare ConferenceFireside Chat: June 11, 2025 at 1:20 p.m. ETMiami, FLThe live and archived webcasts will be available at https://ir.iovance.com/news-events/events-presentations. About Iovance Biotherapeutics, Inc.  Iovance Biotherapeutics, Inc. aims to be the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) therapies for patients with cancer. We are pioneering a transformational approach to cure cancer by harnessing...

Continue reading

Itron Publishes 2024 Corporate Sustainability Report

Advances Emissions Goals, Completes Double Materiality Assessment and Highlights Positive Customer Impact LIBERTY LAKE, Wash., June 10, 2025 (GLOBE NEWSWIRE) — Itron, Inc. (NASDAQ: ITRI), which is innovating new ways for utilities and cities to manage energy and water, today released its 2024 Corporate Sustainability Report. The report details Itron’s environmental, social and governance (ESG) strategy and highlights how the company is empowering cities and utilities to boost efficiency, reduce emissions and build climate-resilient communities equipped to tackle a range of challenges including resource scarcity and infrastructure strain. “At Itron, sustainability is a responsibility we embrace every day,” said Tom Deitrich, president and CEO of Itron. “This year, Itron completed our first enterprise-wide double materiality assessment,...

Continue reading

MACOM IMS 2025 Product Preview – Electronic Countermeasures

LOWELL, Mass., June 10, 2025 (GLOBE NEWSWIRE) — MACOM Technology Solutions Inc. (“MACOM”), a leading supplier of semiconductor products, today announced availability of a wideband front end module (FEM) covering 2 to 18 GHz. Ideal for electronic countermeasures (ECM) and phased array radar applications, the miniature multi-chip ENGSD00088 Transmit/Receive Module integrates a high power 3-stage Gallium Nitride (GaN) Power Amplifier (PA), a 3-stage Gallium Arsenide (GaAs) Low Noise Amplifier (LNA) and a transmit/receive (T/R) switch with a fail-safe antenna termination, all within a compact package. The transmit path delivers 2.5 W typical saturated output power with power added efficiency (PAE) of 24%, along with 25 dB of large signal gain. The receive side provides 27 dB of gain with a low noise figure of 3.5 dB and 26 dBm output...

Continue reading

ONAR Appoints Esteemed Executive Howard Palefsky to the Company’s Board of Directors

Miami, FL, June 10, 2025 (GLOBE NEWSWIRE) — Onar Holding Corporation (OTCQB: ONAR), a leading marketing technology company and network of marketing agencies, today announced the appointment of Howard Palefsky to ONAR’s Board of Directors. Palefsky, an esteemed CEO, VC & PE partner, entrepreneur, board member, chair, and investor with experience across the life sciences, healthcare, and medical technology industries, will also chair the Company’s Governance and Nominating Committee. “It is an honor to welcome Howard to our Board of Directors and as Chair of our Governance and Nominating Committee,” stated Claude Zdanow, CEO of ONAR. “Howard’s extensive expertise with financial markets and public companies, coupled with his experience in healthcare, will be invaluable to our company’s growth and further expansion in the...

Continue reading

VERSES Names Renowned AI and Public Sector Leader Dr. David Bray to Chair Strategic Advisory Council

Council formed to support VERSES® in driving government, enterprise, and global market adoption of Genius™ VANCOUVER, British Columbia, June 10, 2025 (GLOBE NEWSWIRE) — VERSES AI Inc. (CBOE: VERS) (OTCQB: VRSSF) (“VERSES” or the “Company”), a cognitive computing company specializing in next-generation agentic software systems, today announced the appointment of Dr. David Bray, Ph.D., as Chair of its newly formed Strategic Advisory Council. As Strategic Advisory Chair, Dr. David Bray is expected to assist the Company in assembling a council of experts across industry, policy, and technology, aimed at accelerating the Company’s strategic growth and driving market adoption across both private and public sectors. Dr. Bray is a globally recognized expert on AI, data, and cybersecurity. He was named one of the “Top 24 Americans...

Continue reading

Sify Technologies Ltd. Announces Non-Compliance with Nasdaq Listing Requirements due to Resignation of a Director

CHENNAI, India, June 10, 2025 (GLOBE NEWSWIRE) — Sify Technologies Ltd. (Nasdaq: Sify) (the “Company”), a leading integrated information communications technology (or ICT) Solutions and Services provider in India, notified the Nasdaq Stock Market (“Nasdaq”) on May 21, 2025 that, consequent to the resignation of Dr. Ajay Kumar from the Company’s Board of Directors (the “Board”), the Company was in non-compliance with Nasdaq Listing Rule 5605(b)(1), requiring that the majority of the Board be composed of independent directors, and Nasdaq Listing Rule 5605(c)(2), requiring that there be at least three members of the Board’s audit committee. Dr. Kumar resigned to take charge of a constitutional responsibility pursuant to the order of the Hon’ble President of India. The Company also indicated its intent to rely on the cure periods...

Continue reading

Worthington Enterprises Schedules Fourth Quarter 2025 Earnings Call for June 25

COLUMBUS, Ohio, June 10, 2025 (GLOBE NEWSWIRE) — Worthington Enterprises Inc. (NYSE: WOR) will hold its quarterly earnings conference call Wednesday, June 25 at 8:30 a.m. ET. The Company will discuss its fiscal fourth quarter results, which will be released after the market closes on June 24. Please click here to register for the June 25 live audio webcast or visit IR.worthingtonenterprises.com. For those unable to listen live, a replay will be available in the Investors section of the Company’s website approximately two hours after the completion of the call and will be archived for one year.LIVE CONFERENCE CALL DETAILSDate: Wednesday, June 25, 2025Webcast Link: https://events.q4inc.com/attendee/393759253Starting Time: 8:30 a.m. ETConference ID: 1777337Domestic Participants: 888-330-3567   About Worthington...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.